These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21289075)

  • 1. Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.
    Sridar C; Snider NT; Hollenberg PF
    Drug Metab Dispos; 2011 May; 39(5):782-8. PubMed ID: 21289075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.
    Snider NT; Sikora MJ; Sridar C; Feuerstein TJ; Rae JM; Hollenberg PF
    J Pharmacol Exp Ther; 2008 Nov; 327(2):538-45. PubMed ID: 18698000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.
    Snider NT; Walker VJ; Hollenberg PF
    Pharmacol Rev; 2010 Mar; 62(1):136-54. PubMed ID: 20133390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist.
    Snider NT; Nast JA; Tesmer LA; Hollenberg PF
    Mol Pharmacol; 2009 Apr; 75(4):965-72. PubMed ID: 19171674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides.
    Snider NT; Kornilov AM; Kent UM; Hollenberg PF
    J Pharmacol Exp Ther; 2007 May; 321(2):590-7. PubMed ID: 17272674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
    Cravatt BF; Lichtman AH
    Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
    Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.
    Walker VJ; Griffin AP; Hammar DK; Hollenberg PF
    J Pharmacol Exp Ther; 2016 Jun; 357(3):537-44. PubMed ID: 27000802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal and spatial distribution of the cannabinoid receptors (CB1, CB2) and fatty acid amide hydroxylase in the rat ovary.
    Bagavandoss P; Grimshaw S
    Anat Rec (Hoboken); 2010 Aug; 293(8):1425-32. PubMed ID: 20665820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAAH and anandamide: is 2-AG really the odd one out?
    Di Marzo V; Maccarrone M
    Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
    Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
    Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
    Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
    Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
    Kawahara H; Drew GM; Christie MJ; Vaughan CW
    Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
    Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.